• Explore /
  • Poster
  • / Anlotinib plus chemotherapy as first-line therapy for patients with gastrointestinal tumor with unresectable liver metastasis: Updated results from a multi-cohort, multi-center phase II trial ALTER-G-001-cohort C.

Anlotinib plus chemotherapy as first-line therapy for patients with gastrointestinal tumor with unresectable liver metastasis: Updated results from a multi-cohort, multi-center phase II trial ALTER-G-001-cohort C.

Abstract Poster

Authors

null

Junwei Wu

Department of Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Junwei Wu , Chenfei Zhou , Jun Yan , Zhengxiang Han , Chun Wang , Zhiquan Qin , Jinling Jiang , Chunbing Wang , Xinyu Tang , Lingjun Zhu , Jun Chen , Yong Mao , Xiaowei Wei , Chengfang Shangguan , Jun Zhang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT05262335

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 653)

DOI

10.1200/JCO.2024.42.3_suppl.653

Abstract #

653

Poster Bd #

L2

Abstract Disclosures

Similar Posters

First Author: Junwei Wu

First Author: Jing Liu

First Author: Andrew Oar

First Author: Hendrik-Tobias Arkenau